As the bright light emerges at the end of a long COVID-19 tunnel, more focus is being put on the role technology plays in improving patient outcomes. Stakeholders are keen to ensure that health care systems are robust enough to be able to respond effectively to the next crisis.
With dealmaking slumping during 2020, venture capital firms play an even larger role than before in ensuring disruptive technologies can break out of the laboratory and reach commercialization
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?